This startup provides a cardiometabolic risk assessment that integrates individual medical history, NMR-measured biomarkers, and over 40 risk factors from established guidelines to deliver a detailed diagnostic report. The service enables healthcare providers to identify unique risks for diabetes, stroke, and heart attack, facilitating informed decision-making for patient care.
Funding
$300K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Cardiometabolic diseases affect over 100 million Americans and account for $500 billion in annual healthcare spending. Early identification of individual risk factors for diabetes, stroke, and heart attack is critical for improving patient outcomes, but current assessment methods often lack comprehensive integration of relevant data. Traditional risk assessments may not fully incorporate individual medical history, advanced biomarkers, and established clinical guidelines.
Solution
This startup offers a personalized cardiometabolic risk assessment that combines individual medical history, NMR-measured lipoprotein biomarkers, and over 40 risk factors derived from leading clinical guidelines (ACC, ESC, NLA, AACE, ADA, and MESA). The service delivers a detailed diagnostic report that enables healthcare providers to identify each patient’s unique risk profile for metabolic syndrome, type 2 diabetes, and atherosclerotic cardiovascular disease (ASCVD) events. By integrating advanced biomarkers with clinical data, the assessment provides a clearer picture of each patient’s cardiometabolic health, facilitating informed decision-making and personalized treatment plans. The platform streamlines the assessment process, reducing the administrative burden on healthcare providers and enabling more efficient risk stratification. Longitudinal tracking of risk factors is also available.
Target Audience
The primary target audience includes private-practice healthcare providers, hospitals, and employee wellness programs seeking to offer advanced cardiometabolic risk assessment to their patients or employees.
Features
- Integrates individual medical history, NMR-measured lipoprotein biomarkers, and 40+ risk factors from multiple clinical guidelines.
- Provides a comprehensive diagnostic report detailing individual risk for metabolic syndrome, type 2 diabetes, and ASCVD events.
- Utilizes advanced lipoprotein biomarkers to enhance risk stratification accuracy.
- Offers longitudinal tracking of risk factors to monitor disease progression and treatment effectiveness.
- Secure platform reduces administrative burden for healthcare providers, streamlining the assessment process.
- Facilitates personalized treatment plans based on individual risk profiles.
- 5-minute clinical history survey for patients to provide relevant medical information.
- Coordination of blood draw at LabCorp labs for biomarker analysis.